Bleeding is largely unavoidable following syringe needle puncture of biological tissues and, while inconvenient, this typically causes little or no harm in healthy individuals. However, there are ...

Eloquest Healthcare has signed an agreement to promote Omni-stat Medical’s haemostatic products portfolio within the US acute-care market, focusing on vascular access procedures and intensive care ...

Merit Medical Systems has acquired US-based Biolife Delaware, a manufacturer of haemostatic devices, in a $120m deal. The transaction value was paid in cash alongside the assumption of Biolife's ...

Axio Biosolutions, a pioneer in cutting-edge advanced wound care products, announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance to Axiostat gauze, a line of advanced ...